Your browser doesn't support javascript.
loading
An Oral Galectin Inhibitor in COVID-19-A Phase II Randomized Controlled Trial.
Sigamani, Alben; Mayo, Kevin H; Miller, Michelle C; Chen-Walden, Hana; Reddy, Surendar; Platt, David.
Afiliação
  • Sigamani A; Carmel Research Consultancy Pvt. Ltd., Bengaluru 560025, Karnataka, India.
  • Mayo KH; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, 6-155 Jackson Hall, 321 Church Street, Minneapolis, MN 55455, USA.
  • Miller MC; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, 6-155 Jackson Hall, 321 Church Street, Minneapolis, MN 55455, USA.
  • Chen-Walden H; Pharmalectin India Pvt. Ltd., Rangareddy 500039, Telangana, India.
  • Reddy S; Department of Pulmonology, ESIC Medical College and Hospital, Sanath Nagar, Hyderabad 500038, Telangana, India.
  • Platt D; Pharmalectin India Pvt. Ltd., Rangareddy 500039, Telangana, India.
Vaccines (Basel) ; 11(4)2023 Mar 25.
Article em En | MEDLINE | ID: mdl-37112643
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2023 Tipo de documento: Article